00003-4040 Augtyro - CanMED: NDC

Product NDC:

00003-4040

Brand Name:

Augtyro

Generic Name:

Repotrectinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: REPOTRECTINIB

Strength: 40.0

Unit: mg/1

Packages:

Code: 00003-4040-12

Description: 120 CAPSULE in 1 BOTTLE (0003-4040-12)

Effective Date: Dec. 5, 2023

Discontinued:

Code: 00003-4040-60

Description: 60 CAPSULE in 1 BOTTLE (0003-4040-60)

Effective Date: Dec. 5, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

ROS1, TRKA, TRKB, TRKC

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox